Detalles de la búsqueda
1.
Potassium abnormalities in current clinical practice: frequency, causes, severity and management
Medical Principles and Practice. 2015; 24 (3): 271-275
en Inglés
| IMEMR | ID: emr-171526
2.
Serum and urine boron and selenium levels in children with resistant epilepsy
Saudi Medical Journal. 2012; 33 (9): 942-947
en Inglés
| IMEMR | ID: emr-155952
3.
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-429765
4.
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-426984
5.
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-502461
6.
Neutralization of SARS-CoV-2 Omicron pseudovirus by BNT162b2 vaccine-elicited human sera
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268103
7.
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by 3 doses of BNT162b2 vaccine or BA.1 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-494889
8.
Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-486695
9.
Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-516898
10.
Early Computational Detection of Potential High Risk SARS-CoV-2 Variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474095
11.
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-520569
12.
BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-460163
13.
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20176651
14.
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20159905
15.
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20142570
16.
Exposure to BA.4/BA.5 Spike glycoprotein drives pan-Omicron neutralization in vaccine-experienced humans and mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-508818
17.
Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20140533
18.
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21261159
19.
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20245175
20.
A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-280818